About Cardiac Insight
Cardiac Insight is a company based in Bellevue (United States) founded in 2008. Cardiac Insight has raised $37.18 million across 13 funding rounds from investors including SeaChange Fund and Welch Allyn. The company has 23 employees as of December 31, 2022. Cardiac Insight offers products and services including Cardea SOLO and Cardea 20/20. Cardiac Insight operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Bellevue, United States
- Employees 23 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardiac Insight, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.18 M (USD)
in 13 rounds
-
Latest Funding Round
$8 M (USD), Series D
Feb 11, 2020
-
Investors
SeaChange Fund
& 1 more
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardiac Insight
Cardiac Insight offers a comprehensive portfolio of products and services, including Cardea SOLO and Cardea 20/20.
Wearable sensor for continuous ECG monitoring over seven days.
Handheld tool for reliable 12-lead ECG analysis and detection.
People of Cardiac Insight
Unlock access to complete
Funding Insights of Cardiac Insight
Cardiac Insight has successfully raised a total of $37.18M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $8 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cardiac Insight
Cardiac Insight has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include SeaChange Fund and Welch Allyn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provides smart beds, patient monitoring, and care communications for healthcare facilities.
|
Locked | Locked | Locked |
Investor details for Cardiac Insight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cardiac Insight
Investment portfolio details for Cardiac Insight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cardiac Insight
Detailed financials for Cardiac Insight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardiac Insight Comparisons
Peer comparison for Cardiac Insight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cardiac Insight
Cardiac Insight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Online health and wellness tracking and training platform
|
Detailed competitors of Cardiac Insight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardiac Insight
Complete news archive for Cardiac Insight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardiac Insight
Cardiac Insight was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Cardiac Insight is headquartered in Bellevue, United States. It is registered at Bellevue, Washington, United States.
Cardiac Insight is a funded company, having raised a total of $37.18M across 13 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Cardiac Insight is 23.
Cardiac Insight was founded in 2008 and is based in Bellevue, United States. Operations focus on the development of cardiac diagnostics within the sports medicine sector. The platform technology, CardeaScreen, consists of a handheld ECG device integrated with athlete-specific algorithms. These tools enable physicians to analyze and diagnose abnormal cardiac conditions in athletes at the point of care.
Cardiac Insight's top competitors include AliveCor, iRhythm Tech and Biotricity.
Cardiac Insight offers Cardea SOLO and Cardea 20/20.
Cardiac Insight has 2 investors. Key investors include SeaChange Fund, and Welch Allyn.